Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q3 2022 · 10-Q
Revenue$60.72M$60.72M−7.9% vs Q3 2021 Net Income$4.26M$4.26M−44.1% vs Q3 2021 EPS Diluted$0.21$0.21−44.7% vs Q3 2021 Gross Profit$17,725,000−9.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$8,706,000+35.2% Free Cash Flowderived$8,412,000+45.5% Margins · derivedGross margin29.2%−0.6 pt vs Q3 2021
Operating margin8.5%−5.6 pt vs Q3 2021
Net margin7.0%−4.5 pt vs Q3 2021
ended Dec 31, 2021 · filed Feb 4, 2022 · 35 d after period end